Inicio>>Signaling Pathways>> Neuroscience>> Histamine Receptor>>ROS 234 dioxalate

ROS 234 dioxalate

Catalog No.GC12085

El dioxalato de ROS 234 es un potente antagonista H3, con un pKB de 9,46 para el receptor H3 del Íleon de cobayo, un pKi de 8,90 para el receptor H3 de la corteza cerebral de rata y una DE50 de 19,12 mg/kg (ip) in ex vivo de Corteza cerebral de rata.

Products are for research use only. Not for human use. We do not sell to patients.

ROS 234 dioxalate Chemical Structure

Cas No.: 184576-87-2

Tamaño Precio Disponibilidad Cantidad
10mg
215,00 $
Ship Within 7 Days
50mg
907,00 $
Ship Within 7 Days

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Chemical Properties of ROS 234 dioxalate

Cas No. 184576-87-2 SDF
Chemical Name N-(3-(1H-imidazol-5-yl)propyl)-1H-benzo[d]imidazol-2-amine dioxalate
Canonical SMILES OC(C(O)=O)=O.OC(C(O)=O)=O.C1(CCCNC2=NC3=CC=CC=C3N2)=CN=CN1
Formula C13H15N5.2C2H2O4 M.Wt 421.37
Solubility <21.07mg/ml in Water; <21.07mg/ml in DMSO Storage Desiccate at RT
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of ROS 234 dioxalate

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.3732 mL 11.8661 mL 23.7321 mL
5 mM 474.6 μL 2.3732 mL 4.7464 mL
10 mM 237.3 μL 1.1866 mL 2.3732 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of ROS 234 dioxalate

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Reseñas

Review for ROS 234 dioxalate

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ROS 234 dioxalate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.